Please login to the form below

Not currently logged in
Email:
Password:

European Medicines Agency

This page shows the latest European Medicines Agency news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca joins Merck in Brexit stockpiling effort

AstraZeneca joins Merck in Brexit stockpiling effort

The European Medicines Agency (EMA) earlier this month warned that many pharma manufacturers were not ready for Brexit and there was a risk of supply shortages for some medicines if action ... MPs also voted that the government must make the UK remaining

Latest news

More from news
Approximately 1 fully matching, plus 829 partially matching documents found.

Latest Intelligence

  • Protecting patient privacy Protecting patient privacy

    Protecting patient privacy. The most effective approaches  to compliance. As an important move towards greater transparency in the life science sector, plans by the European Medicines Agency (EMA) to create a

  • Drug R&D

    Healthcare terms - Drug R&D.

  • The tipping point The tipping point

    The second factor is the exponential increase in biosimilar approvals. In 2016/17, the European Medicines Agency approved around 20 biosimilars - that’s as many as were approved in the preceding ... is director of the biosimilar medical education

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    The European Medicines Agency released draft guidance last year to offer new thinking on how the industry can incorporate genetic factors into understanding disease and therapeutic response. ... EMA guidance in recent years has touched on the role of

  • Building a bright future Building a bright future

    Herceptin while taking a buffeting over trading in the US, despite European growth contributing strongly to $2.96bn second quarter revenues. ... The European Commission and European Medicines Agency should have a role in encouraging faster work from

More from intelligence
Approximately 0 fully matching, plus 36 partially matching documents found.

Latest appointments

  • Emotive grows medical writing capacity Emotive grows medical writing capacity

    Emotive grows medical writing capacity. Dr Silvana Bardelli and Dr Ann Gilliat join the agency. ... Dr Silvana Bardelli (pictured right) joins as a senior medical writer following a five year career at the Italian Medicines Agency serving as its young

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    Prior to his new role, Forte has held roles for Bone Therapeutics, TxCell, the European Medicines Agency, and  UCB to name a few.

  • Bone Therapeutics strengthens clinical development team Bone Therapeutics strengthens clinical development team

    His career to date has also seen him hold positions such as vice president, global medical affairs at UCB, as well as senior positions at the European Medicines agency, Bristol-Myers

  • EMA’s head of international affairs steps down EMA’s head of international affairs steps down

    The European Medicines Agency's (EMA) Emer Cooke has resigned as head of international affairs, to be replaced ad interim by Agnès Saint-Raymond. ... She has served as head of international affairs since 2013, and is leaving the agency to pursue a new

  • EMA appoints Luc Vanheel as head of administration EMA appoints Luc Vanheel as head of administration

    The European Medicines Agency (EMA) has named Luc Vanheel as the new head of its administration division. ... Vanheel has previously worked as finance and business services director and deputy director and head of plans and programmes at the European

More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest from PMHub

  • Brexit and Pharma: A match made in hell.

    The demand for efficiency and expediency won out when the European Medicines Agency (EMA), a decentralized agency of the EU, began operating in 1995 from its base in London. ... 1. European Federation of Pharmaceutical Industries and Associations. The

  • The Heart of the Matter 7: Reality Dawns

    Likewise, European pharmacovigilance legislation implemented in 2012 means the European Medicines Agency (EMA) is now requesting post-marketing observational studies as part of its approval processes. ... In tandem, as the limitations of the 'gold

  • Getting ready for the Identification of Medicinal Products

    Europe will be the first region to implement IDMP standards; the European Medicines Agency (EMA) will publish the full implementation guidelines for IDMP in 2015, leaving those who wait little time

  • A forward march for adaptive designs

    Very recently the European Medicines Agency (EMA) issued a qualification opinion on a novel statistical methodology for dose finding trials which employs adaptive modelling to optimise the analysis of dose-response ... Also late last year, the Center for

  • Clinical data Transparency

    Amidst extensive criticism the pharmaceutical industry has called for more carrot as an incentive for companies to begin releasing their data; and in the face of two lawsuits even the European ... Medicines Agency (EMA) has had to defend its position on

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics